iA Global Asset Management Inc. boosted its holdings in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 9.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 65,281 shares of the company’s stock after purchasing an additional 5,440 shares during the period. iA Global Asset Management Inc. owned about 0.06% of Encompass Health worth $8,292,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Citizens National Bank Trust Department acquired a new position in shares of Encompass Health in the 3rd quarter worth approximately $26,000. First Horizon Corp bought a new stake in Encompass Health in the third quarter valued at $34,000. Root Financial Partners LLC acquired a new position in Encompass Health during the third quarter worth $39,000. Newbridge Financial Services Group Inc. lifted its holdings in shares of Encompass Health by 112.5% during the second quarter. Newbridge Financial Services Group Inc. now owns 425 shares of the company’s stock valued at $52,000 after acquiring an additional 225 shares during the period. Finally, Employees Retirement System of Texas acquired a new stake in shares of Encompass Health in the 2nd quarter valued at $57,000. 97.25% of the stock is currently owned by institutional investors.
Encompass Health Price Performance
Shares of EHC stock opened at $98.36 on Friday. The firm’s 50 day moving average price is $107.79 and its two-hundred day moving average price is $115.62. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14. Encompass Health Corporation has a 52-week low of $92.53 and a 52-week high of $127.99. The stock has a market cap of $9.90 billion, a PE ratio of 18.59, a PEG ratio of 1.60 and a beta of 0.74.
Analyst Ratings Changes
EHC has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. UBS Group upped their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Thursday, October 2nd. Barclays lifted their target price on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research note on Thursday, October 30th. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Finally, Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Encompass Health in a report on Wednesday, October 8th. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and an average target price of $142.86.
Check Out Our Latest Analysis on Encompass Health
About Encompass Health
Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.
Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.
See Also
- Five stocks we like better than Encompass Health
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- The $100 Trillion AI Story No One Is Telling You
- Trump’s AI Secret: 100X Faster Than Nvidia
- Buy This Stock at 9:30 AM on MONDAY!
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
